Skip to content

BioCryst Pharmaceuticals BCRX Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$173.38M+89.8%$91.34M+8.6%$84.08M-4.5%$88.03M-17.6%$106.88M+0.5%
$66.81M-63.9%$185.01M+43.6%$128.8M-25.1%$172.01M-9.4%$189.9M-12.1%
$854K+325%$201K-65.3%$579K+17.7%$492K+69.1%$291K+38.6%
$109.27M+2.3%$106.82M+17.0%$91.33M+0.2%$91.18M-2.4%$93.39M+18.1%
$28.18M+17.4%$23.99M+2.6%$23.39M+5.3%$22.21M-11.5%$25.1M+8.2%
$8.33M-16.7%$10M+7.2%$9.32M+28.6%$7.25M-17.0%$8.74M-12.6%
$20.54M+59.3%$12.89M-14.0%$14.98M-6.0%$15.94M-8.5%$17.43M+7.9%
$6.09M-16.3%$7.28M+21.7%$5.98M+0.2%$5.97M-24.4%$7.89M+1.6%
$19.11M+11.2%$17.18M+4.1%$16.5M+31.6%$12.54M-12.5%$14.33M+4.2%
$66.81M-63.9%$185.01M+43.6%$128.8M-25.1%$172.01M-9.4%$189.9M-12.1%
$16.22M+18.0%$13.74M
$373.63M-7.6%$404.35M+13.7%$355.68M-10.7%$398.46M-2.8%$409.98M-2.8%
$9.37M+6.7%$8.78M+4.6%$8.4M-0.7%$8.46M+11.4%$7.59M-2.4%
10.1%-0.6%10.7%0.0%10.7%0.0%10.7%-0.2%10.9%0.0%
$19.7M+247%$5.67M+29.3%$4.39M+22.1%$3.59M-25.9%$4.85M-6.0%
$20.57M-66.4%$61.16M+54.2%$39.67M+293%$10.1M-50.8%$20.55M+1.1%
$465.05M-9.6%$514.16M+15.2%$446.42M-2.4%$457.19M-4.8%$480.05M-2.1%
$10.96M-30.8%$15.83M+184%$5.57M-35.2%$8.59M-14.5%$10.05M-13.7%
$119.4M-5.5%$126.41M+6.4%$118.78M+10.9%$107.11M+15.6%$92.64M-18.2%
$5.41M$0
$1.24M-5.9%$1.31M-8.6%$1.44M-11.2%$1.62M-10.0%$1.8M-2.2%
$1.86M+486%$317K-8.9%$348K-11.2%$392K-63.4%$1.07M+14.3%
$1.24M-5.9%$1.31M-8.6%$1.44M-11.2%$1.62M-10.0%$1.8M-2.2%
$8.83M$0
$771K-48.3%$1.49M+23.9%$1.2M-3.1%$1.24M+28.7%$964K-14.0%
$195.39M-0.3%$196.07M+3.1%$190.24M+7.4%$177.16M+26.7%$139.86M-12.8%
$395.2M$0-100%$194.37M-19.9%$242.79M-23.0%$315.41M+0.2%
$11.12M+29.8%$8.57M+1.7%$8.43M-0.8%$8.49M+9.1%$7.78M-1.8%
$2.41M-12.5%$2.75M-13.3%$3.18M-13.2%$3.66M-11.0%$4.11M+3.8%
$12.98M+46.0%$8.89M+1.3%$8.77M-1.2%$8.88M+0.4%$8.85M-0.1%
$1.17M-18.6%$1.44M-17.3%$1.74M-14.7%$2.04M-11.7%$2.31M+8.9%
$1.02B+60.9%$633.31M-24.1%$834.31M-5.1%$878.78M-5.7%$931.97M-3.6%
$0$0$0$0$0
450M0.0%450M0.0%450M0.0%450M0.0%450M+21,483%
$1.67B+20.7%$1.38B+1.8%$1.36B+1.6%$1.34B+1.9%$1.31B+1.8%
-$2.23B-47.9%-$1.51B+14.0%-$1.75B+0.7%-$1.76B+0.3%-$1.77B0.0%
-$368K-1,068%$38K-96.7%$1.14M-30.7%$1.65M+45.4%$1.13M+22.9%
-$553.84M-365%-$119.15M+69.3%-$387.89M+8.0%-$421.59M+6.7%-$451.93M+5.0%
$465.05M-9.6%$514.16M+15.2%$446.42M-2.4%$457.19M-4.8%$480.05M-2.1%
$86.7M-64.5%$244.46M+46.2%$167.15M-7.5%$180.77M-13.6%$209.2M-10.9%
$72.27M$69.25M+17.1%$59.12M+200%$19.74M
$72.27M$69.25M+17.1%$59.12M+200%$19.74M
$799K+3.1%$775K-53.3%$1.66M-13.1%$1.91M-8.3%$2.09M-21.3%
$19.7M+247%$5.67M+29.3%$4.39M+22.1%$3.59M-25.9%$4.85M-6.0%
$20.57M-66.4%$61.16M+54.2%$39.67M+293%$10.1M-50.8%$20.55M+1.1%
$19.7M+247%$5.67M+29.3%$4.39M+22.1%$3.59M-25.9%$4.85M-6.0%
$13.62M+33.5%$10.2M-5.9%$10.84M-6.1%$11.55M-3.6%$11.98M-0.2%
$66.81M-63.9%$185.01M+43.6%$128.8M-25.1%$172.01M-9.4%$189.9M-12.1%
$19.7M+247%$5.67M+29.3%$4.39M+22.1%$3.59M-25.9%$4.85M-6.0%
$8.83M$0
$119.4M-5.5%$126.41M+6.4%$118.78M+10.9%$107.11M+15.6%$92.64M-18.2%
$119.4M-5.5%$126.41M+6.4%$118.78M+10.9%$107.11M+15.6%$92.64M-18.2%
$40.32M+4.8%$38.46M+2.0%$37.69M+5.4%$35.74M+4.2%$34.31M+5.0%
$16.22M+18.0%$13.74M
$2.67M$3.58M-13.5%$4.14M-11.1%$4.65M
$266K$401K-16.1%$478K-12.1%$544K
$2.26M$119K-74.4%$464K-69.3%$1.51M
$1.05M$1.52M+0.5%$1.51M+1.7%$1.49M
$3.04M$1.46M0.0%$1.46M-14.3%$1.71M
$1.59M$1.54M+0.1%$1.54M+54.3%$996K
$486K$1.05M+0.8%$1.04M+2.5%$1.02M
$1.54M$1.51M0.0%$1.51M+7.5%$1.4M
$1.59M$1.54M+0.1%$1.54M+54.3%$996K
$1.11M$496K-54.2%$1.08M-36.1%$1.69M
$18.96M$14.8M-2.3%$15.15M+5.7%$14.32M
$5.98M$6.03M-3.8%$6.27M+14.5%$5.47M
$596K-89.1%$5.48M
$8.83M$0
$1.54M$1.51M0.0%$1.51M+7.5%$1.4M
$1.54M$1.51M0.0%$1.51M+7.5%$1.4M
$1.59M$1.54M+0.1%$1.54M+54.3%$996K
$8.83M$0
$411.82M+3,079%$12.95M-93.8%$207.75M-19.1%$256.95M-22.2%$330.17M+0.2%
254M+19.2%213.1M+1.2%210.5M+0.3%209.9M+0.3%209.2M+0.3%
5M0.0%5M0.0%5M0.0%5M0.0%5M0.0%
00000
00000
$2.54M+19.2%$2.13M+1.2%$2.11M+0.3%$2.1M+0.3%$2.09M+0.3%
$0$0$0$0$0
$72.27M$69.25M+17.1%$59.12M+200%$19.74M
$0.010.0%$0.010.0%$0.010.0%$0.010.0%$0.010.0%
64.8M-5.4%68.5M-3.8%71.2M-0.9%71.8M+16.8%61.5M-1.1%
$1K-99.6%$234K+69.6%$138K+21.1%$114K-60.3%$287K-36.4%
$95K+1,800%$5K-80.8%$26K+30.0%$20K+400%$4K-71.4%
87+16.7%6+200%2
$95K+1,800%$5K-80.8%$26K+30.0%$20K+400%$4K-71.4%
$1K-99.6%$234K+69.6%$138K+21.1%$114K-60.3%$287K-36.4%
$66.81M-63.9%$185.01M+43.6%$128.8M-25.1%$172.01M-9.4%$189.9M-12.1%
$87.38M-64.5%$246.18M+46.1%$168.46M-7.5%$182.11M-13.5%$210.45M-11.0%
$258.97M-22.9%$335.91M+25.6%$267.38M-6.2%$285.2M-9.6%$315.64M-7.5%
$64.83M-5.4%$68.5M-3.8%$71.17M-0.9%$71.79M+16.8%$61.49M-1.1%
$450M0.0%$450M0.0%$450M0.0%$450M0.0%$450M0.0%
$254.01M+19.2%$213.06M+1.2%$210.52M+0.3%$209.91M+0.3%$209.21M+0.3%
$254.01M+19.2%$213.06M+1.2%$210.52M+0.3%$209.91M+0.3%$209.21M+0.3%
$86.7M-64.5%$244.46M+46.2%$167.15M-7.5%$180.77M-13.6%$209.2M-10.9%
$20.57M-66.4%$61.16M+54.2%$39.67M+293%$10.1M-50.8%$20.55M+1.1%
$8$7+16.7%$6+200%$2
$72.27M$69.25M+17.1%$59.12M+200%$19.74M
$16.22M+18.0%$13.74M
$1.24M-5.9%$1.31M-8.6%$1.44M-11.2%$1.62M-10.0%$1.8M-2.2%
$2.67M$3.58M-13.5%$4.14M-11.1%$4.65M
$1.05M$1.52M+0.5%$1.51M+1.7%$1.49M
$0$26K+13.0%$23K+283%$6K
$26K$486K+1.7%$478K+6.0%$451K
$486K$1.05M+0.8%$1.04M+2.5%$1.02M
$0$0$0$0
$266K$401K-16.1%$478K-12.1%$544K
$34.16M+16.2%$29.39M+2.7%$28.62M+5.0%$27.25M-14.8%$31.97M+2.2%
$8.33M-16.7%$10M+7.2%$9.32M+28.6%$7.25M-17.0%$8.74M-12.6%
$18.96M$14.8M-2.3%$15.15M+5.7%$14.32M
$7.43M$9.02M0.0%$9.02M+30.4%$6.92M
$5.98M$6.03M-3.8%$6.27M+14.5%$5.47M
$0.1-6.0%$0.11-0.1%$0.110.0%$0.11-1.9%$0.11+0.1%
$0.010.0%$0.010.0%$0.010.0%$0.010.0%$0.010.0%
$5M0.0%$5M0.0%$5M0.0%$5M0.0%$5M0.0%
$0$0$0$0$0
$0$0$0$0$0
$933K$1.4M0.0%$1.4M0.0%$1.4M
$596K-89.1%$5.48M
$447.5M-3.9%$465.69M-2.3%$476.79M-1.4%$483.58M-3.5%$500.92M-2.5%
$407.18M-4.7%$427.23M-2.7%$439.11M-2.0%$447.84M-4.0%$466.61M-3.0%
330.0%30.0%3
$2.26M$119K-74.4%$464K-69.3%$1.51M
9.9%+0.1%9.8%+0.1%9.6%+0.2%9.4%+0.3%9.1%+0.4%
$0.1+0.8%$0.1+1.5%$0.1+2.2%$0.09+3.5%$0.09+5.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are BioCryst Pharmaceuticals's total assets?
BioCryst Pharmaceuticals (BCRX) holds $465.1M in total assets, down 3.1% year over year.
How much debt does BioCryst Pharmaceuticals have?
BioCryst Pharmaceuticals carries $411.8M in total debt against -$553.8M of shareholders' equity, a debt-to-equity ratio of 0.14.
How much cash does BioCryst Pharmaceuticals have?
BioCryst Pharmaceuticals holds $173.4M in cash and equivalents.
Can BioCryst Pharmaceuticals cover its short-term obligations?
Its current ratio is 1.91 — current assets exceed current liabilities.
Where does BioCryst Pharmaceuticals's balance sheet data come from?
Every line is extracted from BioCryst Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.